UP 202-56, an adenosine analogue, selectively acts via A1 receptors to significantly decrease noxiously-evoked spinal c-Fos protein expression.
Saved in:
| Title: | UP 202-56, an adenosine analogue, selectively acts via A1 receptors to significantly decrease noxiously-evoked spinal c-Fos protein expression. |
|---|---|
| Authors: | Honoré P; Physiopharmacologie du Système Nerveux, INSERM U.161 and EPHE, Paris, France., Buritova J, Chapman V, Besson JM |
| Source: | Pain [Pain] 1998 Apr; Vol. 75 (2-3), pp. 281-93. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7508686 Publication Model: Print Cited Medium: Print ISSN: 0304-3959 (Print) Linking ISSN: 03043959 NLM ISO Abbreviation: Pain Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
